Vivos Therapeutics (VVOS) Shares Outstanding (2019 - 2026)

Vivos Therapeutics (VVOS) has 8 years of Shares Outstanding data on file, last reported at $13.5 million in Q1 2026.

• Quarterly Shares Outstanding rose 128.98% year-over-year to $13.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.5 million (up 128.98% YoY) and the FY2025 annual result came in at $9.3 million, up 57.68% from the prior year.
• Shares Outstanding grew to $13.5 million in Q1 2026 per VVOS's latest filing, from $9.3 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $13.5 million in Q1 2026 and bottomed at $920592.0 in Q1 2022.
• The 5-year median for Shares Outstanding is $2.7 million (2024), against an average of $4.1 million.
• The widest annual swing landed in 2022, when Shares Outstanding plunged 96.0%; it then surged 298.02% in 2024.
• Tracing VVOS's Shares Outstanding over 5 years: stood at $920592.0 in 2022, then surged by 99.21% to $1.8 million in 2023, then jumped by 221.15% to $5.9 million in 2024, then jumped by 57.68% to $9.3 million in 2025, then surged by 45.22% to $13.5 million in 2026.
• Per Business Quant, the three latest VVOS Shares Outstanding figures stand at $13.5 million (Q1 2026), $9.3 million (Q4 2025), and $8.3 million (Q3 2025).

Peer Comparison